In Vitro Activity of New β-Lactamase Inhibitor Combinations against <i>bla</i>_NDM, <i>bla</i>_KPC, and ESBL-Producing Enterobacteriales Uropathogens

• Main Authors: Lubna Razaq (Author), Fakhur Uddin (Author), Shahzad Ali (Author), Shah Muhammad Abbasi (Author), Muhammad Sohail (Author), Nabila E. Yousif (Author), Hala M. Abo-Dief (Author), Zeinhom M. El-Bahy (Author)
• Format: Book
• Published: MDPI AG, 2023-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Antibiotic resistance in uropathogens has increased substantially and severely affected treatment of urinary tract infections (UTIs). Lately, some new formulations, including meropenem/vaborbactam (MEV), ceftazidime/avibactam (CZA), and ceftolozane/tazobactam (C/T) have been introduced to treat infe...